Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
出版年份 2016 全文链接
标题
Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 32, Pages 4235-4243
出版商
Springer Nature
发表日期
2016-02-15
DOI
10.1038/onc.2015.488
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lack of Effect of Metformin on Mammary Carcinogenesis in Nondiabetic Rat and Mouse Models
- (2015) M. D. Thompson et al. Cancer Prevention Research
- Highly specific role of the insulin receptor in breast cancer progression
- (2015) R. Rostoker et al. ENDOCRINE-RELATED CANCER
- Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
- (2014) M. Arnedos et al. ANNALS OF ONCOLOGY
- Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
- (2014) Liyan Jiang et al. BMC CANCER
- Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors
- (2014) R. L. Jones et al. CLINICAL CANCER RESEARCH
- A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
- (2014) I. Puzanov et al. CLINICAL CANCER RESEARCH
- The cancer drug that almost wasn't
- (2014) K. Garber SCIENCE
- Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells
- (2014) Doron Weinstein et al. Endocrine Connections
- IGF-1R as an anti-cancer target--trials and tribulations
- (2013) Helen X. Chen et al. Chinese Journal of Cancer
- Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment
- (2012) D. H. Fagan et al. CANCER RESEARCH
- Quantifying insulin receptor isoform expression in FFPE breast tumors
- (2012) Sean C. Harrington et al. GROWTH HORMONE & IGF RESEARCH
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- Agonism and Antagonism at the Insulin Receptor
- (2012) Louise Knudsen et al. PLoS One
- Biological mechanisms and clinical implications of endocrine resistance in breast cancer
- (2011) Mario Giuliano et al. BREAST
- Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment
- (2011) S C Drury et al. ENDOCRINE-RELATED CANCER
- Insulin receptor and cancer
- (2011) A. Belfiore et al. ENDOCRINE-RELATED CANCER
- The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
- (2011) Marc A. Becker et al. MOLECULAR ENDOCRINOLOGY
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
- (2010) H Zhang et al. ONCOGENE
- Molecular Mechanism and Clinical Implications of Endocrine Therapy Resistance in Breast Cancer
- (2010) Grazia Arpino et al. ONCOLOGY
- Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
- (2010) D. B. Ulanet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells
- (2008) Hua Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
- (2008) Robert J. Paridaens et al. JOURNAL OF CLINICAL ONCOLOGY
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started